Pharmacy and Therapeutics Committee (P&T Committee) definition

Pharmacy and Therapeutics Committee (P&T Committee) or “Committee” means the Committee formulated to review therapeutic classes, conduct clinical

Pharmacy and Therapeutics Committee (P&T Committee) or "committee" means the committee formulated to review therapeutic classes, conduct clinical reviews of specific drugs, recommend additions or deletions to the preferred drug list, and perform other functions as required by the department.

Pharmacy and Therapeutics Committee (P&T Committee) or "committee" means the committee formulated to review therapeutic classes, conduct clinical reviews of specific drugs, recommend additions or deletions to the preferred drug list, and perform other functions as required by the department. The Pharmacy and Therapeutics Committee shall be composed of 8 to 12 members, including the Commissioner of the Department of Mental Health, Mental Retardation and Substance Abuse Services, or his designee. Other members shall be selected or approved by the department. The membership shall include a ratio of physicians to pharmacists of 2:1. Physicians on the committee shall be licensed in Virginia, one of whom shall be a psychiatrist, and one of whom specializes in care for the aging. Pharmacists on the committee shall be licensed in Virginia, one of whom shall have clinical expertise in mental health drugs, and one of whom has clinical expertise in community-based mental health treatment.

Examples of Pharmacy and Therapeutics Committee (P&T Committee) in a sentence

• The Pharmacy and Therapeutics Committee (P&T Committee) shall be a multidisciplinary committee consisting of the Vice President of Patient Services, (preferably) 2 lead clinical nurses, a representative from Microbiology, a representative from Nutritional Support, the Pharmacy Director (or Pharmacy Administrative Coordinator) and Clinical Pharmacist, the Vice Present of Medical Affairs, the Infection Control Nurse and three (3) representatives from the medical staff appointed by the VP of Medical Affairs.

• Pharmacy and Therapeutics Committee: The Amida Care Pharmacy and Therapeutics Committee (P&T Committee) will monitor the pharmacy management system on behalf of both health care providers and recipients of pharmacy services to ensure appropriate and effective drug prescribing and drug utilization.

• A limited listing of Prescription Medications that have been evaluated by Community First’s Pharmacy and Therapeutics Committee (P&T Committee), and have been determined to be safe, appropriate and cost-effective.

• The formulary drug list has been approved by the Centers of Medicare and Medicaid Services (CMS) and/or the state and reviewed by the Pharmacy and Therapeutics Committee (P&T Committee) to make certain that they are clinically appropriate to meet the therapeutic needs of our enrollees in a cost effective manner.

• The Administrative Director shall create an independent Pharmacy and Therapeutics Committee (P&T Committee) to review and consult with the Administrative Director on available evidence of the relative safety, efficacy, and effectiveness of drugs within a class of drugs, for purposes of updating the MTUS Drug List.

• The formulary drug list has been approved by CMS and/or the state and reviewed by the Pharmacy and Therapeutics Committee (P&T Committee) to ensure that they are clinically appropriate to meet the therapeutic needs of our enrollees in a cost effective manner. All formulary utilization management restrictions are approved by CMS and the P&T Committee.

• Data The core analysis of the paper requires new data on both bilateral migration flows disaggregated by skill and measures of migration policies specifically targeting high-skilled migrants.

• The three core variables – resources, household size or type, and housing expenditure – are combined into a formula to calculate entitlement levels.

• The formulary drug list hasbeen approved by CMS and/or the state and reviewed by the Pharmacy and Therapeutics Committee (P&T Committee) to ensure that they are clinically appropriate to meet the therapeutic needs of our enrollees in a cost effective manner.

• Identify the methods and analysis used in the development of the limitation(s); and The CVS Caremark National Pharmacy and Therapeutics Committee (P&T Committee) is an external advisory body of experts from across the United States, composed of 22 independent health care professionals including 18 physicians and four pharmacists, all of whom have broad clinical backgrounds and/or academic expertise regarding prescription drugs.

More Definitions of Pharmacy and Therapeutics Committee (P&T Committee)

Pharmacy and Therapeutics Committee (P&T Committee) or “committee” means the

Pharmacy and Therapeutics Committee (P&T Committee) means an advisory board that shall perform reviews and make recommendations which facilitate the development and maintenance of the Preferred Drug List as described in 10 C.C.R. 2505-10, Section 8.800.17.

Pharmacy and Therapeutics Committee (P&T Committee) means the subcommittee of TDOC’s Statewide CQI Committee. The P&T Committee consists of a variety of clinical professionals, including Physicians, nurses, Psychiatrists, and administrators who meet regularly to identify opportunities for quality improvement, evaluate outcomes through quality indicators, and evaluate risk management processes. The duties of the P&T Committee include developing and maintaining a list of over-the-countermedications approved for availability within Facility commissaries, developing and maintaining the departmental drug formulary, and reviewing the utilization and effectiveness of the pharmacy system as referenced in Appendix B TDOC Policy #113.09.